Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | AVPR1B | P47901 | 4/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 4/20 | 0.34 |
| ▸ | WNT3A | P56704 | 3/20 | 0.34 |
| ▸ | MAPK11 | Q15759 | 3/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.33 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.33 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | BCL6 | P41182 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30765913 | 0.93 | CASP1 (0.38) | CASP1AVPR1BELANEWNT3ANTRK1 | |
| SCHEMBL30765694 | 0.87 | CASP1 (0.38) | CASP1AVPR1BELANEWNT3ANTRK1 | |
| SCHEMBL30765562 | 0.85 | F2 (0.36) | CASP1AVPR1BELANEF2 | |
| SCHEMBL30765577 | 0.85 | AVPR1B (0.36) | CASP1AVPR1BELANENTRK1F2 | |
| SCHEMBL30765765 | 0.85 | CASP1 (0.43) | CASP1KCNH2ELANEWNT3AMAPK11 | |
| SCHEMBL30765956 | 0.84 | CASP1 (0.41) | CASP1KCNH2ELANEWNT3AMAPK11 | |
| SCHEMBL30766007 | 0.81 | AVPR1B (0.37) | CASP1AVPR1BELANENTRK1F2 | |
| SCHEMBL30765632 | 0.80 | CASP1 (0.42) | CASP1AVPR1BELANENTRK1F2 | |
| SCHEMBL30765912 | 0.79 | PRKAG1 (0.36) | CASP1AVPR1BELANEF2 | |
| SCHEMBL30765961 | 0.78 | NTRK1 (0.43) | CASP1ELANENTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4568666-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Alexion Pharmaceuticals, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024035686-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2024-02-15 | — | — | WO | disclosed |